nCAP Medical, Inc. Announces Distribution Agreement with Lovell Government Services, Inc. to Provide NeuroCuple® to Federal Healthcare Systems
HEBER CITY, Utah, October 13, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – nCAP Medical, Inc. (“nCAP Medical” or the “Company”), a medical technology company developing NeuroCuple®, a non-opioid platform for chronic and post-surgical pain, today announced a distribution agreement with Lovell Government Services, Inc. (“Lovell”), making NeuroCuple accessible to federal […]
Aclarion to Present at the 20th Annual LD Micro Main Event
Broomfield, CO, October 13, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion (NASDAQ: ACON) announced today that it will participate in the 20th Annual LD Micro Main Event, taking place October 19-21, 2026 at the Luxe Sunset Boulevard Hotel in Los Angeles, California. Aclarion is scheduled to present on Tuesday, October […]
Aclarion Broadens CLARITY Trial Enrollment Criteria to Accelerate Enrollment
PR Audio: BROOMFIELD, Colo., October 8, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today announced an […]
BioStem Technologies Strengthens Placental Allograft and Umbilical Tissue Patent Portfolio
Newly issued U.S. Patent and pending allowances in the U.S. and Mexico extend protection for the company’s sterile placental allograft, micronized wound care, and umbilical cord extract technologies PR Audio: POMPANO BEACH, Fla., October 1, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BioStem Technologies, Inc. (Nasdaq: BSEM) (“BioStem” or the […]
Aclarion Welcomes NYU Langone Health to CLARITY Trial Network, Now Enrolling at Eleven Sites
PR Audio: BROOMFIELD, Colo., September 29, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today announced NYU […]
BioStem Technologies Opens Hospital Access for VENDAJE® and VENDAJE AC® Through Vizient and Premier
Additions extend BioStem’s hospital channel to its BioRetain® wound care line PR Audio: POMPANO BEACH, Fla., September 4, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BioStem Technologies Inc. (Nasdaq: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft […]
BioStem Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference
POMPANO BEACH, Fla., Sept. 03, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) –BioStem Technologies Inc. (Nasdaq: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced that Company management will present at the H.C. Wainwright 28th Annual Global Investment […]
Aclarion Announces Addition of University of Arizona College of Medicine – Phoenix as CLARITY Trial Site
PR Audio: BROOMFIELD, Colo., August 20, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today announced the […]
BioStem Technologies to Present at the Sidoti MicroCap Conference
POMPANO BEACH, Fla., August 14, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BioStem Technologies Inc. (Nasdaq: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced that Company management will present at the Sidoti MicroCap Virtual […]
American Shared Hospital Services Reports Second Quarter and First Half 2026 Financial Results
Second Quarter Revenue Increased 19% to $8.4 Million Driven by Strong Growth from Direct Patient Services Operating Cash Flow Reached $4.4 Million in First Half of 2026 Conference Call Scheduled for Today at 1:00 PM ET PR Audio: SAN FRANCISCO, Calif., August 13, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – […]